Sign In
to Vote &
Create Storyboards.
 
(Michelle Wheeler) Drug discovery company Proteomics International has completed an important milestone towards the development of a companion diagnostic test with the validation of several of its protein biomarkers.The research team authenticated the panel of biomarkers after taking 508 highly curated disease and control samples. Seven biomarkers were validated at high stringency using the company's proprietary mass spectrometry approach.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard